Press Releases

TGI and Viracor Announce Transplant Advisory Board

June 3, 2020

TruGraf & TRAC Combine to Deliver the Most Comprehensive, Noninvasive Kidney Rejection Diagnostics

May 30, 2020

The American Journal of Transplantation Honors Transplant Genomics Advisor with 2020 Outstanding Article Award

May 28, 2020

Dr. Peter Meintjes Joins Transplant Genomics as Chief Commercial Officer

April 28, 2020

Eurofins – Transplant Genomics Announces TRULO Registry Study to Evaluate Long-Term Clinical Outcomes in Patients Monitored with TruGraf® Testing

April 15, 2020

Remote Testing Options to Support Care for Kidney Transplant Recipients

March 18, 2020

Transplant Genomics, Inc. Appoints Dr. John Holman as VP Medical Affairs

January 10, 2020

MolDX sets TruGraf® reimbursement level

December 05, 2019

Transplant Genomics, Inc. Founders Awarded US Patent Covering Detection of “Silent” Sub-Clinical Rejection in Stable Kidney Transplant Recipients

October 29, 2019

Transplant Genomics, Inc. Confirms TruGraf® Will Receive Medicare Coverage Effective November 25, 2019

October 11, 2019

Medicare Issues Draft Local Coverage Determination (LCD) for Transplant Genomics’ TruGraf® Blood Test as Alternative to Surveillance Biopsies

March 29, 2019

Studies Presented at American Transplant Congress Support Clinical Utility of TGI’s TruGraf® Tests for Management of Kidney Transplant Recipients

June 12, 2018

Clinical Utility Study Indicates Potential for TruGraf™ Test to Replace Surveillance Biopsies in Kidney Transplant Recipients with Stable Renal Function

November 28, 2017

Study Shows TruGraf Blood Test Enables Non-invasive Detection of Immune Quiescent Kidney Transplant Recipients

October 24, 2017

U.S. patent issues for gene expression profiles associated with chronic kidney allograft rejection, licensed exclusively to Transplant Genomics Inc.


Genomic Signature for Predicting Acute Rejection in Liver Transplant Patients to be Presented at the American Transplant Congress

May 1, 2017

Transplant Genomics enters collaboration with Mayo Clinic

June 27, 2016

Transplant Genomics Announces Immunosuppressive Clinical Trials Collaboration with Astellas Pharmaceuticals

May 2, 2016

Transplant Genomics® and Quark Pharmaceuticals Announce Discovery and Development Collaboration

April 14, 2016

Transplant Genomics Announces Expansion of Scientific Advisory Board

January 11, 2016

Transplant Genomics Announces First Four Transplant Centers Participating in TruGraf Early Access Program

December 17, 2015

Transplant Genomics Inc. Supports First ASTS Faculty Research Grant for Biomarker Discovery and Functional Genomics

May 5, 2015

Dr. Roy First Joins Transplant Genomics as Chief Medical Officer

April 30, 2015

Studies Presented at American Transplant Congress Describe Validation of Noninvasive Tests for Post-Transplant Management of Kidney Graft Recipients

April 23, 2015

Transplant Genomics Appoints Brett Jensen Vice President of Sales

November 12, 2014

Studies Presented at World Transplant Congress Support Development of Biomarker Tests Aimed at Improving Transplant Recipient Care

July 28, 2014

Transplant Genomics Inc. Announces Exclusive License to Patent Rights Co-Owned by The Scripps Research Institute and Northwestern University

July 10, 2014